Breast Cancer Genetics

Edited By: Thomas W. Durso CLUE GENE: Barbara Weber's team and two other confirmed a link between BRCA1 and breast and ovarian cancer. L.H. Castilla, F.J. Couch, M.R. Erdos, K.F. Hoskins, K. Calzone, J.E. Garber, J. Boyd, M.B. Lubin, M.L. Deshano, L.C. Brody, F.S. Collins, B.L. Weber, "Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer," Nature Genetics, 8:387-91, 1994. (Cited in 70 publications through August 1996) Comments by Barbara L. Weber, University of

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Edited By: Thomas W. Durso

Barbara Weber
CLUE GENE: Barbara Weber's team and two other confirmed a link between BRCA1 and breast and ovarian cancer.
L.H. Castilla, F.J. Couch, M.R. Erdos, K.F. Hoskins, K. Calzone, J.E. Garber, J. Boyd, M.B. Lubin, M.L. Deshano, L.C. Brody, F.S. Collins, B.L. Weber, "Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer," Nature Genetics, 8:387-91, 1994. (Cited in 70 publications through August 1996) Comments by Barbara L. Weber, University of Pennsylvania

When a team led by University of Utah geneticist Mark Skolnick announced the discovery of a breast-cancer susceptibility gene (Y. Miki et al., Science, 266:66-71, 1994; P.A. Futreal et al., Science, 266:120-2, 1994), it barely beat out several other groups conducting similar research.

But three of the competing teams that were chasing after the same gene made their mark by publishing papers that confirmed the Skolnick squad's result. All three-this paper ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies